Overview

Topical Itraconazole in Treating Patients With Basal Cell Cancer

Status:
Completed
Trial end date:
2017-10-10
Target enrollment:
Participant gender:
Summary
This phase 0 trial studies how well itraconazole gel works in treating patients with basal cell cancer. Itraconazole gel may help to treat basal cell tumors in patients.
Phase:
Early Phase 1
Details
Lead Sponsor:
Jean Yuh Tang
Collaborator:
National Cancer Institute (NCI)
Treatments:
Hydroxyitraconazole
Itraconazole